Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JD.1.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.5.1.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.7.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KW.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LF.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KR.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KR.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.49SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MF.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.1.192SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.39.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
ME.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
LE.1.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDR.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.49.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EG.5.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HV.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.15.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JD.1.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.441SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.509SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.293SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.225SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.637SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.39 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.26 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.103 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.3 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
MB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LE.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
LF.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MD.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LP.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DL.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.1.529 (Omicron)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BF.41.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.39SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.3.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.33 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used